A61K 9/5015
Organic compounds
Official title: {Organic compounds, e.g. fats, sugars}
A61K9/5015 (Organic compounds) appears on 786 US grants and 1,252 published applications in this corpus.
Search patents in A61K- Granted patents
- 786
- Published applications
- 1,252
- Assignees
- 657
- Inventors
- 2,446
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 3 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 5 | 0 |
| 1987 | 4 | 0 |
| 1988 | 7 | 0 |
| 1989 | 23 | 0 |
| 1990 | 12 | 0 |
| 1991 | 9 | 0 |
| 1992 | 9 | 0 |
| 1993 | 17 | 0 |
| 1994 | 6 | 0 |
| 1995 | 7 | 0 |
| 1996 | 7 | 0 |
| 1997 | 12 | 0 |
| 1998 | 6 | 0 |
| 1999 | 7 | 0 |
| 2000 | 5 | 0 |
| 2001 | 17 | 7 |
| 2002 | 9 | 15 |
| 2003 | 11 | 32 |
| 2004 | 7 | 27 |
| 2005 | 7 | 27 |
| 2006 | 7 | 31 |
| 2007 | 6 | 21 |
| 2008 | 5 | 32 |
| 2009 | 3 | 19 |
| 2010 | 14 | 44 |
| 2011 | 12 | 30 |
| 2012 | 21 | 31 |
| 2013 | 26 | 45 |
| 2014 | 25 | 40 |
| 2015 | 21 | 72 |
| 2016 | 31 | 85 |
| 2017 | 47 | 84 |
| 2018 | 44 | 58 |
| 2019 | 39 | 80 |
| 2020 | 47 | 85 |
| 2021 | 48 | 62 |
| 2022 | 36 | 76 |
| 2023 | 32 | 60 |
| 2024 | 43 | 77 |
| 2025 | 51 | 63 |
| 2026 | 25 | 49 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of loading extracellular vesicles29 Sep 2026US 12,746,291 B2Lonza Sales AG
- Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics8 Sep 2026US 12,728,110 B2Flamel Ireland Limited
- Delayed-release formulation of duloxetine1 Sep 2026US 12,721,817 B1Almatica Pharma LLC
- Ergothioneine microcapsule structure with prebiotics, manufacturing method thereof and oral dosage form thereof1 Sep 2026US 12,721,873 B2Leshroom Corporation Limited
- Method for treating cancerous tissue with a nanotherapeutic1 Sep 2026US 12,721,910 B2Imam Abdulrahman Bin Faisal University
- Reconstitutable dry powder formulations and methods of use thereof1 Oct 2026US 2026/0294818 A1
- Systems and methods to provide therapeutic factor viii using ultrasound-mediated nucleic acid delivery1 Oct 2026US 2026/0295083 A1Seattle Children's Hospital d/b/a Seattle Children's Research Institute
- Pharmaceutically active compositions and uses thereof24 Sep 2026US 2026/0283965 A1Xerient Pharma Ltd.
- Fat-soluble nutrient microcapsule as well as preparation method and use thereof24 Sep 2026US 2026/0283967 A1Xinchang Nhu Vitamins Company Ltd.
- Treatment of pancreatic cancer17 Sep 2026US 2026/0272821 A1Exact Therapeutics AS
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles492US 5,215,680 ACavitation-Control Technology, Inc. · 1993
- Controlled release oxycodone compositions466US 5,508,042 AEuro-Celtigue, S.A. · 1996